This study tests whether adding the immunotherapy drug atezolizumab to standard chemotherapy after lung cancer surgery can clear tiny bits of tumor DNA from the blood. About 100 adults with early-stage non-small cell lung cancer who had surgery and still have detectable tumor DNA…
Phase: PHASE2 • Sponsor: Nasser Hanna • Aim: Disease control
Last updated May 14, 2026 12:04 UTC